MedTrace Logo

Multidrug Resistant Gram-negative Pathogen Infections in High Risk Neonates in the Northeast of Mexico

NCT04812847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 597

Last updated 2023-03-01

No results posted yet for this study

Summary

The main objective of this project is to establish a prospective cohort to measure the Gram-negative infection burden in neonates under special care in a regional referral hospital, and to characterize all microorganisms isolates from these subjects at the phenotype and genotype level, specifically in relation to the expression of multi-drug resistance (MDR) associated genes (Molecular characterization of Gram-negative MDR isolates).

Conditions

  • Infant Newborn Disease

Interventions

DIAGNOSTIC_TEST

Identification of MDR characteristics

Identification of MDR in culture media, followed by amplification of related genes from the bacterial isolates

Sponsors & Collaborators

  • Instituto Tecnologico y de Estudios Superiores de Monterey

    lead OTHER

Principal Investigators

  • Victor Javier Lara-Diaz, MD, PhD · Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud

  • Cuauhtémoc Licona-Cassani, PhD · Tecnológico de Monterrey, Centro de Biotecnología FEMSA

  • Marion Genevieve Brunck, PhD · Tecnológico de Monterrey, Escuela de Ingeniería y Ciencias, GIEE on Translational Omics

Eligibility

Min Age
1 Day
Max Age
180 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812847 on ClinicalTrials.gov